Dr Eirini Trichia
Senior Statistical Epidemiologist
Eirini Trichia joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in February 2020 as a Global Health Epidemiologist investigating associations of major risk factors with mortality and disease incidence in a global health context. She started her current position as a Statistical Epidemiologist in the Mexico City Prospective Study in June 2020, where she has been involved in work related to prediction of cardiovascular mortality, associations between adiposity and cognition, and use of large-scale omics data to explore associations with adiposity and diabetes.
Prior to her moving in CTSU, Eirini was a research associate in nutritional epidemiology at the MRC Epidemiology Unit, University of Cambridge, where she also completed her PhD (October 2015 – February 2019). During her postdoc and PhD, she investigated associations of carbohydrate quality and dairy consumption with cardio-metabolic disease incorporating aspects of nutritional, molecular and genetic epidemiology.
Eirini was trained in nutrition (Department of Dietetics and Nutritional Science, Harokopio University of Athens; 2007-2011) and she obtained an MSc degree specialising in nutritional epidemiology and public health (Wageningen University, Netherlands; 2012-2014). After her MSc, Eirini obtained research experience in epidemiology and public health at the Department of Epidemiology and Biostatistics, Imperial College London (2014), as the coordinator of the Nutrition team in the Hellenic National Nutrition and Health Survey in Greece (2014-2015), and as a contributor to a systematic review on the effectiveness of food regulation at schools (Friedman School of Nutrition Science and Policy, Tufts University).
Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults.
Gnatiuc L. et al, (2021), Eur J Prev Cardiol
Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults.
Thomson B. et al, (2021), Int J Epidemiol